Clinical application of CT-guided percutaneous targeted argon-helium cryoablation for soft tissue sarcoma / 南方医科大学学报
Journal of Southern Medical University
;
(12): 229-230, 2006.
Artigo
em Chinês
| WPRIM
| ID: wpr-234151
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the clinical efficacy of percutaneous targeted argon-helium cryoablation for soft tissue sarcoma and analyze the changes in CT findings and side effects in relation to the treatment.</p><p><b>METHODS</b>Thirty-two patients with soft tissue sarcoma were treated with CT-guided argon-helium cryoablation.</p><p><b>RESULTS</b>Three months after the treatment, 52 tumors showed obvious reduction in size with a total complete and partial remission rate of 73.1%. Postoperative CT scanning displayed low-density local necrosis in the tumors after cryotherapy, and consolidation of the lesions was observed at 3 months and lesion disappearance at 1 year after the therapy. The complications included pneumothorax, coughing, hemoptysis, fever, and slight elevation of aminotransferase.</p><p><b>CONCLUSION</b>CT-guided percutaneous targeted argon-helium cryoablation is safe and effective for lung cancer with minimal invasions.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Argônio
/
Sarcoma
/
Cirurgia Geral
/
Tomografia Computadorizada por Raios X
/
Radiografia Intervencionista
/
Resultado do Tratamento
/
Criocirurgia
/
Extremidades
/
Hélio
/
Neoplasias Hepáticas
Limite:
Adulto
/
Idoso
/
Feminino
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
Journal of Southern Medical University
Ano de publicação:
2006
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS